Column Group Gp, LP
10% Owner

Column Group Gp, LP insider trades: Ngm Biopharmaceuticals (NGM) stock buys and sales

10% Owner, Ngm Biopharmaceuticals Last trade Nov 16, 2023 74 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
68
Open-market trades
since 2014
4
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Column Group Gp, LP reports to the SEC

Open-market buys and sales

68 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 16, 2023NGM↑ Buy$16K
Jan 31, 2023NGM↑ Buy$921K
Jan 23, 2023NGM↑ Buy$49K
Jan 20, 2023NGM↑ Buy$191K
Jan 12, 2023NGM↑ Buy$27K
Jan 11, 2023NGM↑ Buy$1.5M
Dec 12, 2022NGM↑ Buy$1K
Nov 22, 2022NGM↑ Buy$202K
Nov 4, 2022NGM↑ Buy$684K
Oct 27, 2022NGM↑ Buy$374K
Oct 26, 2022NGM↑ Buy$595K
Jun 9, 2022NGM↑ Buy$13.3M
Jun 2, 2022NGM↑ Buy$446K
Jun 1, 2022NGM↑ Buy$2.1M
May 27, 2022NGM↑ Buy$309K
May 25, 2022NGM↑ Buy$820K
May 20, 2022NGM↑ Buy$530K
May 18, 2022NGM↑ Buy$2.0M
May 16, 2022NGM↑ Buy$428K
May 12, 2022NGM↑ Buy$1.9M
May 10, 2022NGM↑ Buy$1.3M
Feb 17, 2021CNST↓ Sell$370K
Sep 2, 2020NGM↑ Buy$1.1M
Aug 28, 2020NGM↑ Buy$1.1M
Aug 25, 2020NGM↑ Buy$331K
Aug 17, 2020NGM↑ Buy$1.1M
Jul 30, 2020NGM↑ Buy$13K
Jul 28, 2020NGM↑ Buy$74K
Jul 27, 2020NGM↑ Buy$1.3M
Jul 22, 2020NGM↑ Buy$3K
Apr 8, 2020NGM↑ Buy$1.7M
Apr 7, 2020NGM↑ Buy$2.0M
Apr 2, 2020NGM↑ Buy$3.1M
Mar 25, 2020NGM↑ Buy$3.6M
Mar 20, 2020NGM↑ Buy$3.4M
Mar 20, 2020CNST↑ Buy$937K
Mar 5, 2020NGM↑ Buy$150K
Mar 4, 2020NGM↑ Buy$1.1M
Feb 28, 2020NGM↑ Buy$1.4M
Feb 6, 2020NGM↑ Buy$717K
Nov 11, 2019NGM↑ Buy$180
Nov 4, 2019NGM↑ Buy$101K
Oct 23, 2019NGM↑ Buy$52K
Oct 21, 2019NGM↑ Buy$983K
Oct 16, 2019NGM↑ Buy$1.1M
Oct 11, 2019NGM↑ Buy$555K
Oct 3, 2019CNST↑ Buy$11.3M
Oct 3, 2019CNST↑ Buy$680K
Aug 9, 2019NGM↑ Buy$3.1M
Aug 6, 2019NGM↑ Buy$86K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Column Group Gp, LP's insider trades

Column Group Gp, LP is a 10% owner of Ngm Biopharmaceuticals (NGM). Since Jul 29, 2014, it has reported 67 open-market purchases worth $126.5M and 1 sale worth $370K on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include conversions (4 filings), other transactions (3 filings), option exercises (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NGM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.